Pfam Domains GO Terms
| WT1 |
| zf-C2H2 |
| negative regulation of metanephric glomerulus development |
| negative regulation of metanephric glomerular mesangial cell proliferation |
| regulation of metanephric ureteric bud development |
| visceral serous pericardium development |
| posterior mesonephric tubule development |
| regulation of metanephric glomerular mesangial cell proliferation |
| positive regulation of metanephric ureteric bud development |
| adrenal cortex formation |
| adrenal cortex development |
| negative regulation of glomerular mesangial cell proliferation |
| negative regulation of glomerulus development |
| hemi-methylated DNA-binding |
| positive regulation of DNA methylation |
| negative regulation of female gonad development |
| thorax and anterior abdomen determination |
| double-stranded methylated DNA binding |
| negative regulation of cell proliferation involved in kidney development |
| metanephric S-shaped body morphogenesis |
| negative regulation of gonad development |
| cardiac muscle cell fate commitment |
| regulation of metanephric glomerulus development |
| zygotic determination of anterior/posterior axis, embryo |
| S-shaped body morphogenesis |
| positive regulation of male gonad development |
| negative regulation of metanephros development |
| diaphragm development |
| regulation of male gonad development |
| glomerular basement membrane development |
| cardiac cell fate commitment |
| regulation of glomerular mesangial cell proliferation |
| positive regulation of gonad development |
| regulation of female gonad development |
| regulation of cell proliferation involved in kidney development |
| metanephric mesenchyme development |
| positive regulation of metanephros development |
| C2H2 zinc finger domain binding |
| tripartite regional subdivision |
| muscle cell fate commitment |
| mesenchymal to epithelial transition |
| regulation of glomerulus development |
| anterior/posterior axis specification, embryo |
| glomerular visceral epithelial cell differentiation |
| negative regulation of kidney development |
| renal filtration cell differentiation |
| glomerular epithelial cell differentiation |
| cellular response to gonadotropin stimulus |
| kidney mesenchyme development |
| regulation of gonad development |
| blastoderm segmentation |
| pericardium development |
| glomerular epithelium development |
| metanephric nephron morphogenesis |
| positive regulation of mesonephros development |
| metanephric epithelium development |
| sex determination |
| male genitalia development |
| regulation of metanephros development |
| regulation of DNA methylation |
| adrenal gland development |
| regulation of mesonephros development |
| metanephros morphogenesis |
| response to gonadotropin |
| epithelial cell differentiation involved in kidney development |
| positive regulation of pri-miRNA transcription by RNA polymerase II |
| metanephric nephron development |
| embryonic axis specification |
| regulation of animal organ formation |
| positive regulation of heart growth |
| positive regulation of kidney development |
| cell differentiation involved in kidney development |
| regulation of pri-miRNA transcription by RNA polymerase II |
| branching involved in ureteric bud morphogenesis |
| genitalia development |
| positive regulation of organ growth |
| anterior/posterior axis specification |
| glomerulus development |
| ureteric bud morphogenesis |
| mesonephric tubule morphogenesis |
| cellular response to cAMP |
| regulation of kidney development |
| negative regulation of reproductive process |
| embryonic pattern specification |
| nephron tubule morphogenesis |
| regulation of heart growth |
| nephron epithelium morphogenesis |
| nephron morphogenesis |
| vasculogenesis |
| renal tubule morphogenesis |
| nephron tubule development |
| positive regulation of reproductive process |
| renal tubule development |
| positive regulation of animal organ morphogenesis |
| metanephros development |
| kidney morphogenesis |
| ureteric bud development |
| axis specification |
| mesonephric tubule development |
| mesonephric epithelium development |
| cardiac muscle cell differentiation |
| mesonephros development |
| regulation of organ growth |
| segmentation |
| nephron epithelium development |
| response to cAMP |
| negative regulation of vasculature development |
| cardiocyte differentiation |
| endocrine system development |
| nephron development |
| kidney epithelium development |
| branching morphogenesis of an epithelial tube |
| skeletal muscle organ development |
| male gonad development |
| development of primary male sexual characteristics |
| response to organophosphorus |
| response to purine-containing compound |
| male sex differentiation |
| morphogenesis of a branching epithelium |
| regulation of reproductive process |
| cardiac muscle tissue development |
| morphogenesis of a branching structure |
| positive regulation of developmental growth |
| negative regulation of cell growth |
| positive regulation of DNA metabolic process |
| respiratory system development |
| striated muscle cell differentiation |
| gonad development |
| development of primary sexual characteristics |
| anterior/posterior pattern specification |
| transcription regulatory region DNA binding |
| mesenchyme development |
| negative regulation of growth |
| muscle cell differentiation |
| cell fate commitment |
| germ cell development |
| regulation of animal organ morphogenesis |
| positive regulation of growth |
| sex differentiation |
| kidney development |
| renal system development |
| striated muscle tissue development |
| muscle organ development |
| muscle tissue development |
| epithelial tube morphogenesis |
| camera-type eye development |
| urogenital system development |
| regulation of vasculature development |
| regulation of developmental growth |
| regionalization |
| extracellular matrix organization |
| regulation of DNA metabolic process |
| cellular process involved in reproduction in multicellular organism |
| eye development |
| visual system development |
| sensory system development |
| extracellular structure organization |
| RNA splicing |
| nuclear speck |
| blood vessel morphogenesis |
| gland development |
| regulation of cell growth |
| sequence-specific DNA binding |
| reproductive structure development |
| reproductive system development |
| morphogenesis of an epithelium |
| pattern specification process |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| muscle structure development |
| blood vessel development |
| vasculature development |
| cardiovascular system development |
| heart development |
| cellular response to organic cyclic compound |
| sensory organ development |
| tissue morphogenesis |
| cellular response to organonitrogen compound |
| cellular response to hormone stimulus |
| tube morphogenesis |
| cellular response to nitrogen compound |
| developmental process involved in reproduction |
| regulation of growth |
| negative regulation of cell population proliferation |
| DNA-binding transcription factor activity |
| epithelial cell differentiation |
| gamete generation |
| multicellular organismal reproductive process |
| sexual reproduction |
| zinc ion binding |
| multicellular organism reproduction |
| tube development |
| nucleolus |
| negative regulation of transcription by RNA polymerase II |
| circulatory system development |
| RNA processing |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| negative regulation of programmed cell death |
| response to hormone |
| response to organic cyclic compound |
| negative regulation of developmental process |
| animal organ morphogenesis |
| embryo development |
| multi-organism reproductive process |
| negative regulation of cell death |
| response to organonitrogen compound |
| cellular response to oxygen-containing compound |
| regulation of anatomical structure morphogenesis |
| response to nitrogen compound |
| epithelium development |
| negative regulation of transcription, DNA-templated |
| negative regulation of multicellular organismal process |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| negative regulation of RNA metabolic process |
| positive regulation of developmental process |
| negative regulation of cellular macromolecule biosynthetic process |
| RNA binding |
| reproductive process |
| reproduction |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| response to endogenous stimulus |
| negative regulation of cellular biosynthetic process |
| positive regulation of transcription, DNA-templated |
| regulation of apoptotic process |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of programmed cell death |
| regulation of cell population proliferation |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cell development |
| RNA metabolic process |
| regulation of cell death |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Oligomycin-A 2μM R00 exp25 | -2.27 |
| Metformin 100 to 150μM on day4 R04 exp170 | -2.14 |
| Pimelic-diphenylamide-106 0.5μM R00 exp27 | -2.07 |
| HMS-I1 10μM R06 exp256 | -1.79 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 1/5 |
Expression Distribution